ATE463242T1 - Behandlung von inkontinenz - Google Patents

Behandlung von inkontinenz

Info

Publication number
ATE463242T1
ATE463242T1 AT08160836T AT08160836T ATE463242T1 AT E463242 T1 ATE463242 T1 AT E463242T1 AT 08160836 T AT08160836 T AT 08160836T AT 08160836 T AT08160836 T AT 08160836T AT E463242 T1 ATE463242 T1 AT E463242T1
Authority
AT
Austria
Prior art keywords
incontinence
treatment
gamma
instant invention
aminobutyric acid
Prior art date
Application number
AT08160836T
Other languages
English (en)
Inventor
Catherine Segal
Leslie Magnus
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE463242(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE463242T1 publication Critical patent/ATE463242T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
AT08160836T 1999-04-08 2000-01-27 Behandlung von inkontinenz ATE463242T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08

Publications (1)

Publication Number Publication Date
ATE463242T1 true ATE463242T1 (de) 2010-04-15

Family

ID=22434891

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08160836T ATE463242T1 (de) 1999-04-08 2000-01-27 Behandlung von inkontinenz
AT00905786T ATE413872T1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00905786T ATE413872T1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz

Country Status (13)

Country Link
EP (2) EP1977745B1 (de)
JP (1) JP2002541198A (de)
KR (1) KR20010103053A (de)
AT (2) ATE463242T1 (de)
AU (2) AU779262B2 (de)
CA (1) CA2362026A1 (de)
DE (2) DE60040784D1 (de)
ES (2) ES2341059T3 (de)
HU (1) HUP0200738A3 (de)
IL (1) IL145763A0 (de)
TR (1) TR200102837T2 (de)
WO (1) WO2000061135A1 (de)
ZA (1) ZA200107425B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
ES2341240T3 (es) * 2002-12-13 2010-06-17 Warner-Lambert Company Llc Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
EP1621193A3 (de) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Behandlung nicht-schmerzhafter Blasenstörungen mit Kalziumkanalmodulatoren der alpha2-delta-Untereinheit
AU2003301184A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals Inc METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
EP1721607A1 (de) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Verfahren zur Behandlung von Erkrankungen der unteren Harnwege mittels Modulatoren der glatten Muskulatur und Modulatoren der alpha-2-delta Untereinheit des Kalziumkanals
NZ545884A (en) * 2003-09-11 2010-01-29 Xenoport Inc Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
CA2541752C (en) 2003-10-14 2012-01-03 Xenoport, Inc. Crystalline form of gamma-aminobutyric acid analog
CN101600458A (zh) * 2006-12-22 2009-12-09 瑞蔻达蒂爱尔兰有限公司 采用α2δ配体和NSAID的下泌尿道疾病的联合治疗
EP2240158A2 (de) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilisierte injizierbare pregabalin-formulierung
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US8062870B2 (en) 2008-01-25 2011-11-22 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009560A1 (en) * 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
EP0641330B1 (de) * 1992-05-20 2001-10-17 Northwestern University Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
EP1977745A1 (de) 2008-10-08
DE60044160D1 (de) 2010-05-20
ATE413872T1 (de) 2008-11-15
AU2005200619A1 (en) 2005-03-10
AU779262B2 (en) 2005-01-13
DE60040784D1 (de) 2008-12-24
TR200102837T2 (tr) 2002-03-21
EP1171114A1 (de) 2002-01-16
AU779262C (en) 2000-11-14
JP2002541198A (ja) 2002-12-03
ZA200107425B (en) 2003-02-26
AU2741600A (en) 2000-11-14
HUP0200738A3 (en) 2003-03-28
EP1171114B1 (de) 2008-11-12
CA2362026A1 (en) 2000-10-19
ES2341059T3 (es) 2010-06-14
IL145763A0 (en) 2002-07-25
HUP0200738A2 (hu) 2002-07-29
EP1977745B1 (de) 2010-04-07
KR20010103053A (ko) 2001-11-17
ES2313880T3 (es) 2009-03-16
WO2000061135A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
DE60044160D1 (de) Behandlung von Inkontinenz
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
NO990279L (no) Isobutylgaba og dets derivater for behandling av smerte
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
DE60138129D1 (de) Apparat zur behandlung von zähnen
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
ATE330615T1 (de) Doxycyclin zur behandlung von akne
DE69613693D1 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
FI864246A (fi) N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE60039601D1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
DE69736180D1 (de) Behandlung von manischen erkrankungen
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
DE60122861D1 (de) Behandlung von textilien
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
ATE305778T1 (de) Behandlung von nierenkolik mit gaba-analogen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties